HTB

HomeTrust Bank Awarded Newsweek’s Most Loved Workplace Certification

Retrieved on: 
星期四, 五月 2, 2024

ASHEVILLE, N.C., May 02, 2024 (GLOBE NEWSWIRE) -- HomeTrust Bancshares, Inc. (NASDAQ: HTBI) (“Company”), the holding company of HomeTrust Bank (“Bank” or “HTB”), today announced that the Bank received a coveted Most Loved Workplace 2024 certification by Newsweek.

Key Points: 
  • ASHEVILLE, N.C., May 02, 2024 (GLOBE NEWSWIRE) -- HomeTrust Bancshares, Inc. (NASDAQ: HTBI) (“Company”), the holding company of HomeTrust Bank (“Bank” or “HTB”), today announced that the Bank received a coveted Most Loved Workplace 2024 certification by Newsweek.
  • Created in partnership with the Best Practices Institute, the annual ranking pays tribute to companies that put respect, caring and appreciation for employees at the center of their business model.
  • “We are extremely proud to have HTB recognized by this distinguished certification,” said C. Hunter Westbrook, President & Chief Executive Officer.
  • To learn more about the attributes that garnered this recognition for HomeTrust, please visit: HomeTrust Bank - Most Loved Workplace®

HomeTrust Bancshares, Inc. Announces Retirement of Its Chief Credit Officer and Appointment of Successor

Retrieved on: 
星期二, 一月 23, 2024

As part of the Bank’s strategic succession plan, Kevin Nunley, Senior Vice President and Director of Commercial Credit, will assume the role and responsibilities of Chief Credit Officer upon Mr. Houghton’s retirement.

Key Points: 
  • As part of the Bank’s strategic succession plan, Kevin Nunley, Senior Vice President and Director of Commercial Credit, will assume the role and responsibilities of Chief Credit Officer upon Mr. Houghton’s retirement.
  • Over the past decade, Mr. Houghton has been a key leader in HTB’s transformation into a regional community bank.
  • During his tenure, the Bank has witnessed significant growth and success in its credit management strategies.
  • Mr. Nunley joined HTB in September 2020 and has twenty years of large regional bank experience which includes senior credit officer, portfolio management and relationship manager responsibilities.

70+ Cyber Teams from 28+ Countries Compete in Global Cybersecurity Competition

Retrieved on: 
星期四, 一月 18, 2024

This live-streamed event is one of many scrimmages planned to help players from the International Cybersecurity Challenge (ICC) community prepare for the next global competition in late 2024.

Key Points: 
  • This live-streamed event is one of many scrimmages planned to help players from the International Cybersecurity Challenge (ICC) community prepare for the next global competition in late 2024.
  • "These Global Cyber Games serve as multi-national scrimmages to help global teams scout and train for the International Cybersecurity Challenge Finals," states Katzcy CEO and US Cyber Games Commissioner Jessica Gulick.
  • The Global Cyber Games: New Year Mayhem 2024 will be live-streamed on Saturday, January 27, 2024.
  • This fusion of online games and esports teaches and advances careers in cybersecurity and is recognized as the next evolution of preparing tomorrow's cybersecurity workforce.

Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of Hematology Annual Meeting and Exposition

Retrieved on: 
星期一, 十二月 11, 2023

“Additionally, we are encouraged by the preliminary data from the lowest three dose cohorts from our ongoing Phase 2 clinical trial in MF.

Key Points: 
  • “Additionally, we are encouraged by the preliminary data from the lowest three dose cohorts from our ongoing Phase 2 clinical trial in MF.
  • Data for hematological response and markers of hematopoiesis were presented from exploratory analyses of these mITT24 patients.
  • All data presented from this trial is as of the data cut-off date.
  • 13 of those 18 patients (72.2%) achieved TI for at least 24 weeks over the first 48 weeks of treatment.

Hampshire Trust Bank Embraces Generative Integration with SnapGPT from SnapLogic

Retrieved on: 
星期四, 十一月 9, 2023

Hampshire Trust Bank (HTB), a specialist bank for UK SMEs, today shares its success with SnapLogic , the leader in generative integration.

Key Points: 
  • Hampshire Trust Bank (HTB), a specialist bank for UK SMEs, today shares its success with SnapLogic , the leader in generative integration.
  • HTB is now using SnapGPT - SnapLogic’s generative AI-powered integration solution - to automate and refine its pipelines further, building on its existing success as a long-standing SnapLogic customer.
  • SnapLogic’s SnapGPT solution is being embedded into HTB’s workflow, allowing developers to focus on strategic, creative projects by automating many of their manual tasks.
  • Before SnapGPT, we’d effectively become victims of our own success, as with SnapLogic’s technology, our integration speed and efficiency set very high expectations internally.

Lora Jex Appointed Executive Vice President & Chief Risk Officer

Retrieved on: 
星期二, 九月 5, 2023

ASHEVILLE, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- The board of directors of HomeTrust Bancshares, Inc. (NASDAQ: HTBI) (“Company”), the holding company of HomeTrust Bank (“Bank” or “HTB”), today announced that Lora Jex assumed the position of Executive Vice President and Chief Risk Officer ("CRO") of both the Company and the Bank effective August 31, 2023.

Key Points: 
  • ASHEVILLE, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- The board of directors of HomeTrust Bancshares, Inc. (NASDAQ: HTBI) (“Company”), the holding company of HomeTrust Bank (“Bank” or “HTB”), today announced that Lora Jex assumed the position of Executive Vice President and Chief Risk Officer ("CRO") of both the Company and the Bank effective August 31, 2023.
  • As such she will have oversight of assessing and maturing HTB’s risk appetite to further advance the Bank’s enterprise risk management approach.
  • Ms. Jex will serve as a member of the Operating Committee and report functionally to the Bank’s Audit Committee and administratively to C. Hunter Westbrook, President & Chief Executive Officer of HTB.
  • Finding a CRO who could elevate HTB’s already strong enterprise risk management culture was imperative.” says C. Hunter Westbrook, President & Chief Executive Officer.

Megan Pelletier Promoted to Executive Vice President, Chief Operations & People Officer of HomeTrust Bank

Retrieved on: 
星期一, 七月 31, 2023

ASHEVILLE, N.C., July 31, 2023 (GLOBE NEWSWIRE) -- HomeTrust Bancshares, Inc. (NASDAQ: HTBI) (“Company”), the holding company of HomeTrust Bank (“Bank” or “HTB”), today announced that Megan Pelletier, SPHR, has assumed the position of Executive Vice President, Chief Operations & People Officer effective today.

Key Points: 
  • ASHEVILLE, N.C., July 31, 2023 (GLOBE NEWSWIRE) -- HomeTrust Bancshares, Inc. (NASDAQ: HTBI) (“Company”), the holding company of HomeTrust Bank (“Bank” or “HTB”), today announced that Megan Pelletier, SPHR, has assumed the position of Executive Vice President, Chief Operations & People Officer effective today.
  • In her new role, Pelletier will retain responsibility for Human Resources and assume responsibility for Deposit and Loan Operations and Project Management functions.
  • Ms. Pelletier’s tenure with HomeTrust began in May 2022 when she joined the Bank as Chief People Officer and led an initiative for HomeTrust to be named A Best Place to Work.
  • Previously, Pelletier was a team member at CommunityOne Bank, SunTrust Bank (now Truist) in Charlotte, NC, and Wellington Management Company in Boston, MA.

Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program and Preclinical Data from its ALK2 Inhibitor Program at the 28th Annual Congress of the European Hematology Association

Retrieved on: 
星期五, 六月 9, 2023

In addition, Keros announced preclinical data evaluating activin receptor-like kinase-2 (“ALK2”) inhibition, as well as its combination with RKER-050, as potential treatment options for anemia of inflammation.

Key Points: 
  • In addition, Keros announced preclinical data evaluating activin receptor-like kinase-2 (“ALK2”) inhibition, as well as its combination with RKER-050, as potential treatment options for anemia of inflammation.
  • Of these patients, 37 had completed at least 24 weeks of treatment or discontinued as of the data cut-off date (the “evaluated RP2D patients”).
  • Data for hematological response and markers of hematopoiesis were presented from exploratory analyses of these evaluated RP2D patients.
  • By targeting ALK2 inhibition to suppress hepcidin, RKER-216 increased iron availability for erythropoiesis and partially rescued anemia in CKD mice.

PlayCyber® and Hack The Box (HTB) Host Global Cybersecurity Scrimmage

Retrieved on: 
星期四, 十二月 15, 2022

ASHBURN, Va., Dec. 15, 2022 /PRNewswire/ -- PlayCyber® and Hack The Box (HTB) are pleased to announce their partnership in hosting a global cybersecurity scrimmage—New Year's Blitz—on Saturday, January 7, 2023. This live-stream event, which represents HTB's 5th Hacking Battleground Live Tournament, is one of many scrimmages planned to help players from the International Cybersecurity Challenge (ICC) community prepare for the International Cybersecurity Championship & Conference (IC3) hosted by the United States in 2023.

Key Points: 
  • ASHBURN, Va., Dec. 15, 2022 /PRNewswire/ -- PlayCyber and Hack The Box (HTB ) are pleased to announce their partnership in hosting a global cybersecurity scrimmage New Year's Blitz on Saturday, January 7, 2023.
  • Haris Pylarinos, Founder and CEO at Hack The Box highlights, "Hacking Battlegrounds are a highly effective way to learn and practice hands-on cyber skills through a fun, gamified approach.
  • Such tournaments are also an opportunity for aspiring hackers and cybersecurity professionals to grow their 'hacking mindset,' needed to match the current threat landscape."
  • The Global Cyber Games New Year's Blitz will be live streamed on Saturday, January 7, 2023, starting at 9:00 AM ET | 14:00 UTC.

Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2022 Financial Results

Retrieved on: 
星期四, 八月 4, 2022

LEXINGTON, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulmonary, and musculoskeletal disorders with high unmet medical need, today provided a business update and reported financial results for the quarter ended June 30, 2022.

Key Points: 
  • We continued the positive momentum for our pipeline programs into the second quarter of 2022.
  • In May 2022, Keros announced preliminary topline data from the Phase 1 clinical study of KER-012 in healthy postmenopausal women.
  • Keros reported a net loss of $27.3 million in the second quarter of 2022 as compared to a net loss of $15.6 million in the second quarter of 2021.
  • Research and development expenses were $23.3 million for the second quarter of 2022 as compared to $10.0 million for the same period in 2021.